Emergent BioSolutions (NYSE:EBS) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Emergent BioSolutions beat estimated earnings by 5.39%, reporting an EPS of $4.5 versus an estimate of $4.27.
Revenue was up $140.20 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $2.71 which was followed by a 37.07% drop in the share price the next day.
Here's a look at Emergent BioSolutions's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 2.35 | 1.54 | 1.12 | 3.19 |
| EPS Actual | -0.36 | 0.33 | 1.53 | 3.67 |
| Revenue Estimate | 486.84M | 398.93M | 358.47M | 563.60M |
| Revenue Actual | 329.00M | 397.50M | 343.00M | 583.00M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
